|Articles|November 23, 2011

EpiCor Receives NDI Approval

While Embria says its ingredient is protected under FDA’s grandfather clause, company president Paul Faganel said that the move provides additional assurance for its customers and manufacturing partners.

EpiCor, the immune-balancing ingredient from Embria Health Sciences (Ankeny, IA), has received New Dietary Ingredient (NDI) notification from the FDA, the company reports.

While Embria says its ingredient is protected under FDA’s grandfather clause, company president Paul Faganel said that the move provides additional assurance for its customers and manufacturing partners.

Newsletter

From ingredient science to consumer trends, get the intel you need to stay competitive in the nutrition space—subscribe now to Nutritional Outlook.